WELCOME TO THE HAABB!

The Heart of America Association of Blood Banks is a nonprofit, professional organization dedicated to improving Transfusion Medicine by fostering the exchange of information and bringing education opportunities to blood bank and transfusion medicine professionals.  The HAABB hosts two annual meetings for the Kansas City & St Louis areas. 

 

 

 

 

 

 

 

HAABB 44th Annual Spring Meeting Review


The 44th Annual Spring Meeting of the HAABB was held on


May 12th and May 13th, 2011 at Harrah's Hotel in North Kansas City, MO.


The HAABB president was Beth Jones.


Two exciting new changes occurred at this meeting:


The new logo was unveiled &


The school of the 2011 HAABB scolarship winner


was also rewarded a $500 check.

2010 - 2011 HAABB Board of Directors


______________________________________________________________________




VENDORS for the 2011 SPRING MEETING



A special THANK YOU to all of the vendors who particpated in this year's meeting.  Vendor participation ensures that we can continue these programs.
In addition to exhibiting at the meeting, many supported the organization
by sponsoring education sessions and providing raffle prizes for the
Thursday evening reception and Friday lunch break.

 

 


EXHIBITORS

 

American Red Cross

Bio-Rad

Charter Med

Community Blood Center

Computype

Fenwal

Fresenius Kabi

Haemonetics Software Solutions

Helmer, Inc.

HemoCue

Hemo Bioscience

Immucor

MedAlliance Group Inc.

Mediware

Mississippi Valley Regional Blood Center

Novo Nordisk

Ortho Clinical Diagnostics, Inc.

Pall

Quotient Biodiagnostics

 



SESSION SPONSORS

 

Ortho Clinical Diagnostics, Inc. - sponsoring Ann Steiner's presentation

Haemonetics Software Solutions - sponsoring Dr.Robert L Thurer's presentation

Fenwal - sponsoring Peyton Metzel's presentation

Centers for Disease Control - sponsoring Alexis Harvey's presentation




Click here to see pictures of the vendors


Click here to see pictures of reception prize winners




 

 

******************************************************************************




Click here to see pictures of the speakers




Thursday, May 12th, 2011:    Presentation Reviews

 

 

0845-1130 THURS AM SESSION

 

 

0845-0910  Case Study:  PRENATAL PERPLEXOR  

                        Carrie Easley, Stormont-Vail Regional Medical Center, Topeka, KS and

                        Mary Kowalski, Community Blood Center, Kansas City, KS

 

 

0910-1000  Presentation:  INNOVATIONS IN BLOOD MANAGEMENT: HOW BLOOD TRACK CAN IMPROVE BLOOD

                    USAGE AND PATIENT SAFETY IN YOUR HOSPITAL

                        Dr.Robert L.Thurer, Medical Director

                        Haemonetics, Braintree, MA

 

1000-1015  BREAK 

 

1015-1040  Presentation:  COPING WITH SICKLE CELL ANEMIA, THROUGH A MOTHER'S EYES

                         Erika Perkins, President

                         Sickle Cell Disease Association of America - Uriel Owens Chapter

 

                          BIOGRAPHY:

                          Individual with Sickle Cell Trait (hemoglobin genotype AS)

                          Parent of a child with Sickle Cell Anemia

                          President of Sickle Cell Disease Association of America - Uriel Owens Chapter

                          Bachelor of Science in Public Admininstration & Finance

                          Master's of Business Administration 

 

                   OBJECTIVES:

                          1.    To bring awareness to being tested for sickle cell trait.

                          2.    To become educated and know the complications that are associated

                                    with Sickle Cell Anemia

                          3.    To become involved in the Sickle Cell Anemia Association.

 

 

1040-1130  Presentation:  TRANSFUSION OF PLASMA

                        Dr. Lejla Music-Aplenc

                        Children's Mercy Hospital, Kansas City, MO

 

 

1130-1300  Lunch and Opening of Vendor Exhibits

 

 

 

                       - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

1300-1600 THURS PM SESSION

 

 

1300-1430  Presentation:  HANDLING CONFLICT WITH OPTIMISM AND HUMOR

                        Bobbe Sommer, PhD

                        Keynote Speaking, San Clemente, CA

 

                    BIOGRAPHY: 

                        Bobbe Sommer, PhD is a licensed psychotherapist as well as an International Speaker in great demand. 

                        She has addressed many of the Fortune 500 companies from AT&T to Xerox.  She has been cited by

                        Working Woman Magazine as the "Hottest Speaker" on the leadership training circuit, appeared on Oprah,

                        interviewed by Maria Shriver, and published "Psycho-Cybernetics 2000," a best selling professional and

                        leadership book published by Prentice Hall as well as author of numerous articles, DVD's and CD's on goal

                        setting and proactive approaches to instigate initiative.  Her new book, LEADERSLIPS, is due out in spring

                        of 2012.  Dr. Sommer has presented several times at the AABB conference as well as numerous other

                        medical professional associations.  It is a pleasure to welcome Dr. Sommer to the Heartland which is also

                        her homeland!

 

                       For more information please visit her website at:    www.KeynoteSpeaking.com 

 

                     SUMMARY

                        Conflict is inevitable and confrontation mandatory if we are to resolve conflict with positive and proactive                         results.  Learn the four communication styles and the eight steps to meeting conflict with optimism and                         success.  Be able to recognize and deflect the Red Herring and remain in control even when you get your                         chain jerked!!                     

 

                     OBJECTIVES:

                        1.  Identify and disarm the Red Herring

                        2.  Remain assertive rather than aggressive (while keeping your sanity)

                        3.  Differentiate destructive arguments from constructive debate

 

 

1430-1500  BREAK

 

 

1500-1525  Case Study:  ATTACK OF THE CLONES

                        Christina Barron, MT(ASCP)SBB

                        American Red Cross, St Louis, MO

                    

                    BIOGRAPHY:

                        Chris graduated from St. Louis University with a degree in Medical Tecnology.  She worked in the Blood

                        Banks of St. John's Mercy Medical Center, St Mary's Hospital, and Barnes Hospital.  Chri joined the

                        Reference Laboratory at the Missouri-Illinois Region American Red Cross in 1988.  She has held positions

                        as a Technologist, Lead Technologist, Manager, Change Control Administrator, and Technical Support

                        Specialist.

 

                    SUMMARY/OBJECTIVES:

                        The use of monoclonal reagents for blood typing has resulted in the discovery of new antigens, but has

                        also caused difficulties when Technologists are faced with discrepancies in the blood bank.  This

                        presentation will highlight several cases found in our laboratory and will compare various reagent

                        manufacturers and the clones used in their monoclonal reagents.

 

 

1525-1615  Presentation:  COMPARING AND CONTRASTING ANTIBODY DETECTION METHODS

                        Ann Steiner, MT(ASCP)SBB

                        Ortho Clinical Diagnostics, Ann Arbor, MI

 

                    BIOGRAPHY:

                        My current position is Blood Bank Technical Specialist for Ortho Diagnostics where I support gel manual

                        and automated testing.  Previously I was the supervisor of the Reference Laboratory at the University

                        of Michigan and I have served as the Chair of the AABB Committee on Reference Laboratories and the

                        Rare Donor File.

 

                    OBJECTIVES:

                        1.    List at least 3 serological results that may signify the need for an antibody identification study.

                        2.    List at least 3 variables that can affect the results of the pretransfusion antibody screen test (PTAS).

                        3.    List at least 4 of the goals of the PTAS.

                        4.    List at least 4 causes of a false positive or unreadable PTAS.

                        

 

1615-1800    Reception/Vendor Exhibits

 

 

 

________________________________________________________________________________________

________________________________________________________________________________________

 

 

Friday May 13th, 2011:  Presentation Reviews

 

 

0845 - 1200 FRI AM SESSION

 

 

0845-0910  Case Study:  MASSIVE TRANSFUSION PROTOCOL FOR OB PATIENTS

                        Conna Hiltner, CLS(ASCP)

                        Shawnee Mission Medical Center, Merriam, KS

 

                        BIOGRAPHY:

                            I took my training at KU Medical Center, and have worked at Shawnee Mission Medical Center since

                            then, for the past 40 years.  I have been in theTransfusion Service for 30 years.  In addition to

                            Transfusion Service, I also serve as the hospital's Tissue Coordinator.  I enjoy traveling with my family,

                            most recently traveling to Russia with my husband.  I also keep busy with genealogy, cooking and

                            volunteering with my 2 daughters at a Girl Scout equestrian program.                                            

                

                        OBJECTIVES: This presentation describes the:

                            1.    OB cases that highlighted the need for a Massive Transfusion Protocol

                            2.    Interdisciplinary team formed to develop it

                            3.    Final protocol

                            4.    On-going evaluation of effectiveness

 

 

 

0910-1000  Presentation:  FOLLOW THAT PLATELET!

                        Peyton Metzel

                        Fenwal, Inc., Lake Zurich, IL

 

1000-1030  BREAK/VENDOR EXHIBITS

 

1030-1200  Presentation:  NATIONAL HEALTHCARE SAFETY NETWORK (NHSN) BIOVIGILANCE COMPONENT

                    DEMONSTRATION

                        Alexis Harvey, Public Health Analyst

                        CDC Contractor - Emergint Technologies, Inc., Atlanta GA

 

                        BIOGRAPHY: 

                            Alexis is trained in microbiology and epidemiology and has experience in tissueprocurement and

                            processing.  She is now a Public Health Analyst in the Office of Blood, Organ, and Other Tissue Safety

                            at the Centers for Disease Control and Prevention helping to build Biovigilance in the United States.

 

                        OBJECTIVES: 

                            1.    To demonstrate major features of the Hemovigilance Module of the National

                                   Healthcare Safety Network (NHSN). 

                            2.    To explain how CDC will protect the hemovigilance data received from facilities.

                            3.    To explain how participating facilities can use their own data for process improvements.

                            4.    To describe the steps necessary for facilities to join the NHSN.

 

 

1200-1315    Lunch and Vendor Exhibits

 

 

1315-1330    Business Meeting/Scholarship Paper

 

 

                       - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

1330 - 1615 FRI PM SESSION

 

 

1330-1420  Presentation:  BLOOD MANAGEMENT

                        Dr. Lowell Tilzer

                        K.U. Medical Center, Kansas City, KS

 

                        BIOGRAPHY: 

                            Tilzer received his bachelor, MD, and PhD degrees, as well as his residency training at the University of

                            Kansas.  He served on the School of Medicine faculty until 1992.  Before returning to KU Medical Center,

                            he was CEO for the American Red Cross Southwest Blood Region.  Dr. Tilzer returned to the Kansas

                            University Medical Center in 2004 as professor of Pathology for the KU School of Medicine.  He serves

                            as Medical Director of the Clinical Laboratory and Chairman of the Department of Pathology and

                            Laboratory Medicine. 

 

                            Tilzer is co-author of the Laboratory Test Handbook, third edition, the second largest selling book in

                            laboratory medicine.  He has also published more than 50 articles in peer-reviewed journals.  His

                            accomplishments include being the first to implement bar coding for laboratory specimen process,

                            discovery of progesterone receptors in meningiomas and being the first to suggest progestin therapy for

                            treatment of inoperable meningiomas.  Tilzer also invented and patented novel techniques for

                            extracting DNA and RNA using gel barrier technology, which led to the founding of Isogene

                            Biotechnology. 

 

                        OBJECTIVES:

                            1.    Learn the adverse reactions due to:

                                    a)    Red Blood Cells

                                    b)    Platelets

                                    c)    Plasma 

                            2.    Using evidence based medicine, understand when to use the major blood components

                            3.    Use of alternatives to blood components in a bleeding patient

 

 

1420-1445  Case Study:  YOU ARE WHAT YOU EAT!  AN INTERESTING TTP/HUS CASE STUDY

                        Misty Fowler

                        Saint Luke's Hospital, Kansas City, MO

 

1445-1500  BREAK 

 

 

1500-1525  Case Study:  A SICKLE IN A PICKLE      

                        Julie Kirkegaard

                        Community Blood Center, Kansas City, MO

 

 

1525-1615  Presentation:  CHARLES DREW AND YOU:  THE VALUE OF DIRECTED DONATION 

                        Ruby Russell, Clinical Laboratory Scientist

                        Saint Luke's Hospital, Kansas City

 

                        BIOGRAPHY:

                            American Red Cross - Executive Board Member of the Charles Drew Program, Kansas City, MO

                            Clinical Laboratory Scientist 

 

                        INTRODUCTION:

                            Imagine yourself lying in a hospital bed needing a transfusion and you've just been told you have

                            formed your 4th alloantibody and your transfusion will have to wait.  This is the reality for some

                            sickle cell patients across the country.  So how does the blood service industry follow the new Healthy

                            People Initiatives for 2020 to "Prevent illness and disability related to blood disorders and the use of

                            blood products"1?  The American Red Cross, Charles Drew Program, uses directed donations to improve

                            blood safety for patients with Sickle Cell Anemia. 

 

                        OBJECTIVES:

                            1.    Charles Drew Program Overview

                            2.    Directed Donation importance/impact

                            3.    Statistics for Charles Drew/Directed Donation

                            4.    Personal accounts:

                                    ο    Ruby Russell (Kansas City Charles Drew Board Member)

                                    ο    Earnestine Diamond (KCMO Charles Drew Board Member & oldest living sickle cell patient)

                                    ο    Rachel Young (Kansas City Charles Drew Board Member)

                            5.    How your organization/you can personally get involved

 

                        WEBSITE for Healthy People Initiatives:        

                            1 http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=4